Log In
BCIQ
Print this Print this
 

INT230-6

  Manage Alerts
Collapse Summary General Information
Company Intensity Therapeutics Inc.
DescriptionIntratumoral aqueous solution comprising cisplatin and vinblastine
Molecular Target Dendritic cells
Mechanism of ActionImmune modulation
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat refractory malignant solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$0.3M

$0.3M

0


 Deals Details
Get a free BioCentury trial today